An early feasibility study to evaluate the safety and efficacy of Delphi Revascularization device for clot retrieval. This is for hospital patients with Anterior circulation ischemic stroke. Up to 8hrs of symptom onset or last known well time.
An early feasibility study to evaluate the safety and first pass effect technical assessment of Delphi Revascularization device for clot retrieval in Anterior circulation ischemic stroke in the intracranial ICA, MCA M1 and proimal dominant MCA M2, up to 8hrs of symptom onset or Last known well
At least 18 years of age at time of consent;
The patient or patient’s LAR has signed and dated an ICD using the Institutional Review Board (IRB) and Medtronic Approved ICD and agrees to comply with protocol requirements. Health Insurance Portability and Accountability Act of 1996 (HIPAA) authorization has been provided and signed by the patient or patient’s LAR
Has baseline National Institutes of Health Stroke Scale (NIHSS) ≥ 8;
Able to be treated within 8 hours of stroke symptom onset or Last Known Normal (LKN);
Confirmed LVO in the anterior circulation (i.e., intracranial ICA, M1 or proximal dominant M2) as confirmed by CTA or MRA;
Has a Pre-stroke Modified Rankin Score (mRS) ≤ 1;
Has an Alberta Stroke Program Early CT Score (ASPECTS) 6 – 10;
Use of Solitaire device as primary approach to thrombectomy, with or without conjunct aspiration
Let us know how the study team can reach you. If you do not hear back within 2 business days, reach out to the study team directly at the
contact information above or email firstname.lastname@example.org and someone will assist you.
Your information will be shared only with the research study team for recruitment purposes and designated CTSI personnel for project quality
assurance and will remain confidential. Your information will be stored indefinitely. Should you no longer want this information to be provided
in the aforementioned ways, please contact email@example.com.